Question 1

What is the catalog number for MAPRE1, NT (MAPRE1, Microtubule-associated protein RP/EB family member 1, APC-binding protein EB1, End-binding protein 1) (PE) discontinued?

Accepted Answer

The catalog number for MAPRE1, NT (MAPRE1, Microtubule-associated protein RP/EB family member 1, APC-binding protein EB1, End-binding protein 1) (PE) discontinued is 038190-PE.

Question 2

What sizes are available for MAPRE1, NT (MAPRE1, Microtubule-associated protein RP/EB family member 1, APC-binding protein EB1, End-binding protein 1) (PE) discontinued?

Accepted Answer

MAPRE1, NT (MAPRE1, Microtubule-associated protein RP/EB family member 1, APC-binding protein EB1, End-binding protein 1) (PE) discontinued is available in the following size(s): 200 µL.

Question 3

Is MAPRE1, NT (MAPRE1, Microtubule-associated protein RP/EB family member 1, APC-binding protein EB1, End-binding protein 1) (PE) discontinued in stock?

Accepted Answer

MAPRE1, NT (MAPRE1, Microtubule-associated protein RP/EB family member 1, APC-binding protein EB1, End-binding protein 1) (PE) discontinued

Selected Variant

038190-PE

Size: 200 µL

Product Specifications

Clonality

Pab

Question 4

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

Question 5

What is the shelf life of this product?

Accepted Answer

Shelf life and expiration dates vary by product and are shown on the product listing and label. Products used beyond their expiration date are not eligible for performance-related returns or refunds, so please check the lot number and expiry before use.

Question 6

What expression system was used for this recombinant protein?

Accepted Answer

The expression system, such as E. coli, HEK293, or insect cells, is listed on the datasheet under production details, which can affect post-translational modifications relevant to your application.